STAAR Surgical (STAA) Competitors $28.37 -0.20 (-0.70%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$28.38 +0.00 (+0.02%) As of 08/15/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STAA vs. ICUI, XRAY, QDEL, NEOG, CERS, OSUR, UTMD, ANIK, WST, and COOShould you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include ICU Medical (ICUI), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), and Cooper Companies (COO). These companies are all part of the "health care supplies" industry. STAAR Surgical vs. Its Competitors ICU Medical DENTSPLY SIRONA QuidelOrtho Neogen Cerus OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies STAAR Surgical (NASDAQ:STAA) and ICU Medical (NASDAQ:ICUI) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation. Do analysts recommend STAA or ICUI? STAAR Surgical currently has a consensus target price of $20.67, indicating a potential downside of 27.15%. ICU Medical has a consensus target price of $179.00, indicating a potential upside of 48.00%. Given ICU Medical's stronger consensus rating and higher possible upside, analysts plainly believe ICU Medical is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STAAR Surgical 0 Sell rating(s) 10 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00ICU Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media prefer STAA or ICUI? In the previous week, ICU Medical had 9 more articles in the media than STAAR Surgical. MarketBeat recorded 16 mentions for ICU Medical and 7 mentions for STAAR Surgical. ICU Medical's average media sentiment score of 0.66 beat STAAR Surgical's score of 0.59 indicating that ICU Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 4 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ICU Medical 5 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders believe in STAA or ICUI? 96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 96.1% of ICU Medical shares are owned by institutional investors. 0.6% of STAAR Surgical shares are owned by company insiders. Comparatively, 1.5% of ICU Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, STAA or ICUI? STAAR Surgical has higher earnings, but lower revenue than ICU Medical. ICU Medical is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTAAR Surgical$313.90M4.48-$20.21M-$1.93-14.70ICU Medical$2.38B1.25-$117.69M-$1.52-79.57 Is STAA or ICUI more profitable? ICU Medical has a net margin of -1.56% compared to STAAR Surgical's net margin of -42.45%. ICU Medical's return on equity of 7.24% beat STAAR Surgical's return on equity.Company Net Margins Return on Equity Return on Assets STAAR Surgical-42.45% -16.11% -12.54% ICU Medical -1.56%7.24%3.50% Which has more volatility and risk, STAA or ICUI? STAAR Surgical has a beta of 0.61, indicating that its share price is 39% less volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. SummaryICU Medical beats STAAR Surgical on 13 of the 17 factors compared between the two stocks. Get STAAR Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STAA vs. The Competition Export to ExcelMetricSTAAR SurgicalMED/DENTAL IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.42B$15.06B$5.67B$9.82BDividend YieldN/A1.50%3.79%4.08%P/E Ratio-14.7017.9230.5825.12Price / Sales4.482.42464.24116.42Price / CashN/A15.9937.4059.05Price / Book4.183.729.096.18Net Income-$20.21M$430.42M$3.25B$264.89M7 Day Performance4.07%0.00%7.42%4.22%1 Month Performance66.00%2.36%5.50%2.02%1 Year Performance-25.16%13.02%30.67%24.22% STAAR Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STAASTAAR Surgical2.8242 of 5 stars$28.37-0.7%$20.67-27.2%-22.1%$1.42B$313.90M-14.701,211ICUIICU Medical4.2902 of 5 stars$130.06+2.1%$192.67+48.1%-23.5%$3.14B$2.38B-33.9615,000News CoverageAnalyst ForecastInsider TradeXRAYDENTSPLY SIRONA4.9747 of 5 stars$14.31+0.1%$19.60+37.0%-46.0%$2.85B$3.79B-3.1514,000Dividend AnnouncementQDELQuidelOrtho4.3181 of 5 stars$24.11+5.7%$44.33+83.9%-41.9%$1.54B$2.78B-4.856,600News CoveragePositive NewsNEOGNeogen3.5403 of 5 stars$4.68+0.4%$7.50+60.3%-67.7%$1.01B$894.66M-0.932,110Trending NewsCERSCerus3.2637 of 5 stars$1.30+2.4%$3.50+169.2%-43.4%$242.77M$185.14M-13.00290Positive NewsOSUROraSure Technologies2.4747 of 5 stars$3.12+3.7%$3.00-3.8%-33.0%$225.15M$185.83M-7.43840Positive NewsUTMDUtah Medical Products2.7798 of 5 stars$56.78+3.3%N/A-18.7%$178.49M$40.90M15.18180Positive NewsANIKAnika Therapeutics4.3692 of 5 stars$8.77+1.5%$18.00+105.2%-65.4%$124.57M$119.91M-2.11300WSTWest Pharmaceutical Services4.6988 of 5 stars$238.34-0.4%$320.71+34.6%-15.9%$17.20B$2.89B35.6810,600News CoveragePositive NewsCOOCooper Companies4.0137 of 5 stars$71.45+0.8%$96.73+35.4%-20.4%$14.17B$3.90B34.6816,000Positive News Related Companies and Tools Related Companies ICU Medical Competitors DENTSPLY SIRONA Competitors QuidelOrtho Competitors Neogen Competitors Cerus Competitors OraSure Technologies Competitors Utah Medical Products Competitors Anika Therapeutics Competitors West Pharmaceutical Services Competitors Cooper Companies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:STAA) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredTrump's New Plan to “Make China Pay”Trump's AI Masterplan Could Crush China The White House just unleashed would could be the most aggressive e...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STAAR Surgical Company Please log in to your account or sign up in order to add this asset to your watchlist. Share STAAR Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.